Skip to content
hello@apconix.com
ApconiX Logo
  • Our Services
    • Toxicology and DMPK Consultancy
      • Drug Project Toxicology
      • Drug Metabolism and Pharmacokinetics (DMPK)
      • Toxicology Specialists
      • Study Monitoring
      • Project Management
      • Due Diligence
      • Inhalation Toxicology
      • Genetic Toxicology
      • Reproductive Toxicology
      • Safety and Secondary Pharmacology
      • Immunotoxicology
      • Medical Devices
      • OELs and PDEs
    • Ion Channel Screening
      • Cardiac Liability
      • CNS Liability
      • Additional Capabilities
    • Safety Science
      • Target Safety Assessments
      • Drug Safety
      • Data Science
  • About Us
    • Meet The Team
  • What Else We Do
  • Join Us
  • Scientific Resources
    • Bulletins
      • 2025 Q3
      • 2025 Q2
      • 2025 Q1
      • 2024 Q3 & Q4
      • Archives
        • 2024 Q2
        • 2024 Q1
        • 2023 Q4
        • 2022 Q4
        • 2022 Q3
        • 2021 Q4
        • 2021 Q2 & Q3
        • 2021 Q1
        • 2020 Q4
        • 2020 Q3
        • 2020 Q2
        • 2020 Q1
        • 2019 Q4
        • 2019 Q3
    • Video Resources
    • Publications
    • Posters
    • Brochures
  • Latest
    • Our Newsletters
  • Get In Touch
  • Our Services
    • Toxicology and DMPK Consultancy
      • Drug Project Toxicology
      • Drug Metabolism and Pharmacokinetics (DMPK)
      • Toxicology Specialists
      • Study Monitoring
      • Project Management
      • Due Diligence
      • Inhalation Toxicology
      • Genetic Toxicology
      • Reproductive Toxicology
      • Safety and Secondary Pharmacology
      • Immunotoxicology
      • Medical Devices
      • OELs and PDEs
    • Ion Channel Screening
      • Cardiac Liability
      • CNS Liability
      • Additional Capabilities
    • Safety Science
      • Target Safety Assessments
      • Drug Safety
      • Data Science
  • About Us
    • Meet The Team
  • What Else We Do
  • Join Us
  • Scientific Resources
    • Bulletins
      • 2025 Q3
      • 2025 Q2
      • 2025 Q1
      • 2024 Q3 & Q4
      • Archives
        • 2024 Q2
        • 2024 Q1
        • 2023 Q4
        • 2022 Q4
        • 2022 Q3
        • 2021 Q4
        • 2021 Q2 & Q3
        • 2021 Q1
        • 2020 Q4
        • 2020 Q3
        • 2020 Q2
        • 2020 Q1
        • 2019 Q4
        • 2019 Q3
    • Video Resources
    • Publications
    • Posters
    • Brochures
  • Latest
    • Our Newsletters
  • Get In Touch
The small molecule CLP257 does not modify activity of the K+/Cl- co-transporter KCC2 but does potentiate GABA A receptor activity.
  • View Larger Image CLP257

Read more here: RA Cardarelli, K Jones, LI Pisella, HJ Wobst, LJ McWilliams, PM Sharpe, MP Burnham, DJ Baker, I Chudotvorova, J Guyot, L Silayeva, DH Morrow, N Dekker, S Zicha, PA Davies, J Holenz, ME Duggan, J Dunlop, RJ Mather, Q Wang, I Medina, NJ Brandon, TZ Deeb and SJ Moss. The small molecule CLP257 does not modify activity of the K+/Cl- co-transporter KCC2 but does potentiate GABA A receptor activity. Nat Med. 23(12):1394-1396. 2017. 

By Karen Jones|2024-09-23T15:22:17+01:00December 1st, 2017|Publications, Ion Channels|Comments Off on The small molecule CLP257 does not modify activity of the K+/Cl- co-transporter KCC2 but does potentiate GABA A receptor activity.

Share This Story, Choose Your Platform!

FacebookXRedditLinkedInTumblrPinterestVkEmail

About the Author: Karen Jones

Dr Karen Jones PhD. Karen is a Senior Research Scientist with over 10 years of experience in the pharmaceutical industry within the early drug discovery setting. Karen’s area of expertise is in the development of Ion Channel and GPCR assays which are used for compound screening in various formats from small scale bespoke experiments up to large scale fully automated screens. Karen is skilled at problem solving and has a proven track record of delivery with difficult targets leading to publications in peer reviewed journals.

Related Posts

ApconiX Welcomes Stanley Boamah and Zac Murray
ApconiX Welcomes Stanley Boamah and Zac Murray

ApconiX Welcomes Stanley Boamah and Zac Murray

ApconiX Welcomes Dr Sean Brennan
ApconiX Welcomes Dr Sean Brennan

ApconiX Welcomes Dr Sean Brennan

ApconiX Welcomes Sophia Tomlinson
ApconiX Welcomes Sophia Tomlinson

ApconiX Welcomes Sophia Tomlinson

ApconiX Welcomes Dr Louisa Zolkiewski
ApconiX Welcomes Dr Louisa Zolkiewski

ApconiX Welcomes Dr Louisa Zolkiewski

ApconiX Welcomes Dr Katie Newman
ApconiX Welcomes Dr Katie Newman

ApconiX Welcomes Dr Katie Newman

Apconix

Our Services
About Us
What Else We Do
Join Us
Scientific Resources
Latest
Get In Touch
Privacy Policy
Standard Terms & Conditions

What We Do

Ion Channel Screening
Safety Science
Toxicology and DMPK Consultancy

News & Views

  • ApconiX Welcomes Dr Simone Stahl
  • ApconiX Welcomes Stanley Boamah and Zac Murray
  • ApconiX Welcomes Dr Sean Brennan

Get In Touch

e: hello@apconix.com

Alderley Park,
Alderley Edge,
Cheshire,
SK10 4TG,
UK

Copyright ApconiX | All Rights Reserved | Website by Greenlight Web
Page load link

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in {setting]settings{/setting].

ApconiX
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Necessary

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Marketing

This website uses the following additional cookies:

(List the cookies that you are using on the website here.)

Go to Top